TNF blockers will have boxed warning cancer risk

by Anil Kumar



The U.S. Food and Drug Administration is requiring stronger warnings in the prescribing information for a class of drugs known as TNF blockers or TNF inhibitors.

Tumor necrosis factor (TNF) promotes the inflammatory response, which in turn causes many of the clinical problems associated with autoimmune disorders such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriasis and refractory asthma.

These disorders are sometimes treated by using a TNF inhibitor or TNF blocker.

The warnings, which include an updated boxed warning, highlight the increased risk of cancer in children and adolescents who receive these drugs to treat juvenile rheumatoid arthritis, the inflammatory bowel disorder, Crohn's disease, and other inflammatory diseases.

In addition, the FDA is working with manufacturers to explore new ways to further define the risk of cancer in children and adolescents who use these drugs.

TNF blockers target and neutralize tumor necrosis factor-alpha (TNF-a), a protein that, when overproduced in the body due to chronic inflammatory diseases, can cause inflammation and damage to bones, cartilage and tissue. The drugs in this class include Remicade (infliximab), Enbrel (etancercept), Humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab).

This action is based on the completion of an investigation first announced by the FDA in June 2008. An analysis of U.S. reports of cancer in children and adolescents treated with TNF-blockers showed an increased risk of cancer, occurring after 30 months of treatment on average. About half of the cancers were lymphomas, a type of cancer involving cells of the immune system. Some of the reported cancers were fatal.

Additional required updates to the prescribing information include incorporation of reports of psoriasis associated with the use of TNF blockers.


(Anil Kumar -- sub-editor compiled and published TNF blockers will have boxed warning cancer risk at HealthNewsTrack on August 5, 2009 sourced from U.S. Food and Drug Administration - http://www.fda.gov/)

Cancer - recent articles and current news stories:

- Susan G. Komen stops funding breast cancer programs at Planned Parenthood
- Additional breast surgery common after partial mastectomy
- Erivedge approved for skin cancer metastatic basal cell carcinoma
- New lung cancer test could accurately guide treatment for people with lung cancer
- Regorafenib improves survival of colorectal cancer patients

Cancer article/news source:

Read more health articles from U.S. Food and Drug Administration and health articles from USA.

Cancer - search related terms:

Autoimmune disorder, Cancer, Lymphoma, Prescribing information, TNF, TNF blocker, TNF inhibitor, Tumor necrosis factor,
Cancer books,

Subscribe to Health News by Email

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.13